Clinical Trials Directory

Trials / Completed

CompletedNCT05083052

Propolis in Reducing Dentin Hypersensitivity

Propolis in Reducing Dentin Hypersensitivity: a Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Universidade Federal do Para · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Objective: This randomized, double-blind, parallel, placebo-controlled clinical trial aims to evaluate the effect of propolis with two distinct concentrations (10% and 15%), and the impact on volunteers' quality of life. Materials and methods: Volunteers meeting the inclusion and exclusion criteria will be randomized and allocated into three groups: Group 1- placebo - toothpaste without active ingredient, Group 2- toothpaste with 10% propolis and Group 3. - toothpaste with 15% propolis. Number of teeth will be used as sample unit, totaling 22 teeth per group. Volunteers will receive oral hygiene instruction with guidance to brush their teeth three times a day with toothpaste corresponding to the groups in which they will be allocated for 30 days. The evaluation of dentin hypersensitivity will be performed with three (3) evaluation times: baseline (immediately before the beginning of treatment), 15 and 30 days, through tactile and evaporative stimuli, using the visual analog scale (VAS). The self-reported evaluation of the volunteers will be done through a questionnaire before the beginning and after one month with the completion of the research to determine the impact of treatment on their quality of life. The data regarding HD in VAS, if present normal distribution, will be used Two-way analysis of variance (ANOVA) with Tukey's post hoc for comparison between treatments. However, if the data show anormal distribution, Friedman to compare the different times in the same group (intra group), and Kruskal Wallis to make the comparison between groups (inter group). To evaluate the QEHD ordinal data, Wilcoxon and Mann-Whitney tests will be used. Bioestat 5.3 (Belém, Pará, Brazil) will be used, considering an alpha level of 5%.

Conditions

Interventions

TypeNameDescription
OTHERPropolis 15%oothpaste formulation with 15% propolis.
OTHERPropolis 10%Toothpaste formulation with 10% propolis.
OTHERPlaceboFormulation of toothpaste without active ingredient.

Timeline

Start date
2020-11-05
Primary completion
2021-11-05
Completion
2021-12-20
First posted
2021-10-19
Last updated
2024-05-07

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT05083052. Inclusion in this directory is not an endorsement.